The Evidence Speaks (June 2022)
This edition includes preparing patients for colorectal surgery, exome sequencing's impact on health care utilization, and cardiovascular events in people with glomerular diseases
Read MoreFebruary 28, 2022
This edition includes preparing patients for colorectal surgery, exome sequencing's impact on health care utilization, and cardiovascular events in people with glomerular diseases
Read More
In Part 2 of our series on rare diseases, Dr. Larry Lynd discusses what the future could look like for the diagnosis and treatment of rare genetic disorders
Read More
CHÉOS Scientists are leading eight of the projects funded in this round, plus a further fourteen projects are supported by CHÉOS Scientists as co-investigators
Read More
CHÉOS Scientists are testing the cost-effectiveness of adding a new blood test to improve prostate cancer screening
Read More
The newest member of our team is an expert in outcomes research, administrative data, and epidemiology…and lived experience
Read More
Includes oral corticosteroid use in asthma, social assistance and emergencies, and mental health and surgical outcomes
Read More
In recognition of Rare Disease Day, CHÉOS Scientist Dr. Larry Lynd shares an insight into his work investigating the diagnosis, treatment, and management of rare diseases
Read More
A new investigation from the CHÉOS Health Economics Program indicates the framework could speed up generic entry to Canadian public health plans
Read More
New research from the CHÉOS Health Economics Program finds market factors and pricing policies may be to blame
Read More
CHÉOS Scientists are testing the cost-effectiveness of a new blood test that aims to avoid the unnecessary health complications and costs of current methods
Read More